Xu, S., He, L., Ding, K., Zhang, L., Xu, X., Wang, S., & Qian, X. (2020). Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly by Attenuating PERK Pathway-Induced Fibrosis. Drug Des Devel Ther.
Chicago-tyylinen lähdeviittausXu, Shujuan, Lianjun He, Keke Ding, Lingling Zhang, Xinhui Xu, Sheng Wang, ja Xueyi Qian. "Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly By Attenuating PERK Pathway-Induced Fibrosis." Drug Des Devel Ther 2020.
MLA-viiteXu, Shujuan, et al. "Tanshinone IIA Ameliorates Streptozotocin-Induced Diabetic Nephropathy, Partly By Attenuating PERK Pathway-Induced Fibrosis." Drug Des Devel Ther 2020.
Varoitus: Nämä viitteet eivät aina ole täysin luotettavia.